PapersFlow Research Brief
Cancer Research and Treatment
Research Guide
What is Cancer Research and Treatment?
Cancer Research and Treatment is the application of nanotechnology in the treatment and diagnosis of cancer, including nanoparticles, biospectroscopic analysis of cancer cells, anti-cancer nano drugs, DNA/RNA interaction, photodynamic therapy, pharmacokinetics, and therapeutic nanomedicine using drug delivery systems, with exploration of synchrotron radiation.
This field encompasses 15,601 works focused on nanotechnology for cancer diagnosis and therapy. Studies cover nanoparticles, biospectroscopic analysis of cancer cells, development of anti-cancer nano drugs, and drug delivery systems. Research also examines photodynamic therapy, pharmacokinetics, DNA/RNA interactions, and synchrotron radiation applications.
Topic Hierarchy
Research Sub-Topics
Nanoparticle Drug Delivery for Cancer
Researchers develop and evaluate nanoparticles like liposomes and polymeric micelles for targeted delivery of chemotherapeutics to tumor sites. Studies optimize pharmacokinetics, tumor accumulation, and controlled release profiles.
Photodynamic Therapy Nanoparticles
This sub-topic focuses on nanoparticle-photosensitizer conjugates for cancer photodynamic therapy, including upconversion nanoparticles for deep tissue penetration. Research assesses singlet oxygen generation and therapeutic outcomes.
Synchrotron Radiation in Cancer Nanomedicine
Scientists utilize synchrotron X-ray techniques for high-resolution imaging of nanoparticle interactions with cancer cells and biodistribution studies. Applications include microbeam radiation therapy combined with nanoparticles.
Biospectroscopic Analysis of Cancer Cells
Research employs infrared and Raman spectroscopy to characterize biochemical changes in cancer cells and monitor nanoparticle-induced alterations. Multivariate analysis identifies biomarkers for early diagnosis.
Anti-Cancer Nano Drug Pharmacokinetics
Studies investigate absorption, distribution, metabolism, and excretion of anti-cancer nanodrugs, focusing on tumor penetration and clearance pathways. Pharmacodynamic models predict efficacy and safety.
Why It Matters
Nanotechnology in cancer research enables targeted drug delivery systems that improve pharmacokinetics and therapeutic outcomes, as shown in multifunctional nanocarriers for precise treatment. Folkman et al. (1971) isolated a tumor factor responsible for angiogenesis, suggesting inhibition of this factor could arrest solid tumor growth by blocking blood vessel formation in tumors. Torchilin (2006) demonstrated multifunctional nanocarriers that integrate diagnostics and therapy, enhancing efficacy in cancer treatment through combined imaging and drug release mechanisms. These approaches address challenges in conventional therapies by reducing side effects and improving specificity, with applications in photodynamic therapy and anti-cancer nano drugs.
Reading Guide
Where to Start
"Multifunctional nanocarriers" by Torchilin (2006) provides an accessible entry into nanotechnology-based drug delivery systems central to cancer treatment, explaining core concepts like targeting and multifunctionality with 1234 citations.
Key Papers Explained
"ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS" by Folkman et al. (1971) established the role of angiogenesis in tumor growth (1660 citations), laying groundwork for targeted therapies. This connects to "Multifunctional nanocarriers" by Torchilin (2006), which applies nanotechnology for drug delivery to inhibit such vascular processes (1234 citations). "Cancer: Principles and Practice of Oncology" by Gunn (1994) contextualizes these advances in broader oncology practice (1814 citations).
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work builds on nanocarriers and angiogenesis inhibition, with the cluster's 15,601 papers emphasizing pharmacokinetics and photodynamic therapy integration. No recent preprints or news available, so frontiers remain in synchrotron radiation for biospectroscopy and DNA/RNA nano interactions.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Diagnostic and Statistical Manual of Mental Disorders, 5th Edi... | 2013 | American Psychiatric P... | 4.4K | ✕ |
| 2 | Trypan Blue Exclusion Test of Cell Viability | 2015 | Current Protocols in I... | 2.5K | ✕ |
| 3 | Fundamentals of Clinical Trials | 2015 | — | 2.2K | ✕ |
| 4 | Nerve growth factor. | 1968 | Physiological Reviews | 2.0K | ✕ |
| 5 | Advances in Experimental Medicine and Biology | 1986 | Neurochemistry Interna... | 1.9K | ✕ |
| 6 | Cancer: Principles and Practice of Oncology | 1994 | JAMA | 1.8K | ✕ |
| 7 | ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS | 1971 | The Journal of Experim... | 1.7K | ✓ |
| 8 | Progress in Clinical and Biological Research | 1979 | Journal of Clinical Pa... | 1.6K | ✓ |
| 9 | Journal of pharmaceutical and biomedical analysis | 1983 | Journal of Chromatogra... | 1.3K | ✕ |
| 10 | Multifunctional nanocarriers☆ | 2006 | Advanced Drug Delivery... | 1.2K | ✕ |
Frequently Asked Questions
What role do nanoparticles play in cancer treatment?
Nanoparticles serve as carriers in therapeutic nanomedicine for targeted drug delivery to cancer cells. They improve pharmacokinetics and enable photodynamic therapy. This cluster includes studies on anti-cancer nano drugs using such systems.
How is biospectroscopic analysis used in cancer research?
Biospectroscopic analysis examines cancer cells to support diagnosis and treatment development. It integrates with nanotechnology approaches in this field. Synchrotron radiation enhances these analyses for precise cellular studies.
What is the focus of therapeutic nanomedicine in cancer?
Therapeutic nanomedicine develops drug delivery systems for cancer treatment. It covers anti-cancer nano drugs and DNA/RNA interactions. Pharmacokinetics optimization is a key aspect.
How does tumor angiogenesis factor relate to cancer treatment?
"ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS" by Folkman et al. (1971) identified a mitogenic factor from tumors that promotes capillary endothelial cell growth. The factor consists of RNA and protein components. Blocking it may inhibit tumor angiogenesis and arrest solid tumor growth.
What are multifunctional nanocarriers in cancer therapy?
"Multifunctional nanocarriers" by Torchilin (2006) describes systems that combine drug delivery with diagnostic functions. They target cancer cells effectively. This advances therapeutic nanomedicine.
What is the scope of this cancer research cluster?
The cluster contains 15,601 works on nanotechnology for cancer diagnosis and treatment. Key areas include nanoparticles, photodynamic therapy, and synchrotron radiation. Growth rate over 5 years is not available.
Open Research Questions
- ? How can inhibition of tumor angiogenesis factor be optimized for clinical cancer treatment?
- ? What improvements in pharmacokinetics are achievable with multifunctional nanocarriers in vivo?
- ? How does synchrotron radiation enhance biospectroscopic analysis of cancer cells for diagnosis?
- ? Which DNA/RNA interactions with nanoparticles yield the most effective anti-cancer nano drugs?
- ? Can photodynamic therapy using nano drugs fully replace traditional chemotherapy?
Recent Trends
The field maintains 15,601 works with no specified 5-year growth rate.
Multifunctional nanocarriers by Torchilin continue influencing drug delivery, while Folkman et al. (1971) angiogenesis findings underpin ongoing tumor inhibition strategies.
2006No recent preprints or news reported.
Research Cancer Research and Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cancer Research and Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers